Seehra Jasbir bought KROS

April 2, 2026 · Form 4 insider transaction

Seehra Jasbir bought 55,000 shares of Keros Therapeutics, Inc. at $0.30 per share, a transaction worth $16.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.